Posts Tagged ‘Therapeutic Goods Administration’

Widespread shortages of EpiPen, an epinephrine autoinjector for the treatment of anaphylaxis, have been resolved. The Therapeutic Goods Administration (TGA) confirmed this week the supply had returned to normal following a worldwide shortage that lasted almost a year. Issues with overseas manufacturers of the Mylan product in April 2018 had international ramifications, forcing those with…